Prognomics

Prognomics LTD was established in 2014 as a spin-out company from Swansea University, UK, with an aim to develop graphene-based sensors.

The company is developing a number of methods to graft bio-receptors (for example, antibodies) to graphene in order to get sensitive and selective detection. The target markets include the medical and commercial sectors.